Global Indocyanine Green for Injection Supply, Demand and Key Producers, 2026-2032
The global Indocyanine Green for Injection market size is expected to reach $ 151 million by 2032, rising at a market growth of 7.0% CAGR during the forecast period (2026-2032).
Indocyanine Green for Injection is a sterile injectable diagnostic drug with indocyanine green as the active ingredient, typically supplied as a 25 mg lyophilized powder for injection or a solvent-combined package. It is mainly used for liver function and hepatic blood flow assessment, ophthalmic choroidal angiography, tissue perfusion assessment, biliary visualization, lymphatic tracing, sentinel lymph node mapping and fluorescence-guided surgery. Key upstream materials include pharmaceutical-grade indocyanine green API, formulation excipients such as sodium iodide, water for injection, sterile vials, rubber stoppers, aluminum-plastic caps, lyophilized formulation packaging materials, light-protective packaging materials, and quality control consumables for sterility testing, assay testing and impurity control. Major downstream customers include general hospitals, ophthalmic specialty hospitals, hepatobiliary surgery departments, gastrointestinal surgery departments, oncology surgery departments, vascular surgery departments, transplant centers, breast surgery departments, ambulatory surgery centers and pharmaceutical distributors. On an ex-factory finished-formulation basis, global production capacity in 2025 is estimated at about 1.80 million units, with sales volume of approximately 1.127 million units, an average ex-factory price of around USD 79.5 per unit and an industry gross margin range of approximately 52%–68%. The product is a low-volume, high-value diagnostic drug with strong regulatory attributes, and its manufacturing requires strict aseptic processing, lyophilization control, visible particulate control, assay and impurity testing, sterility assurance and stability management.
The market for Indocyanine Green for Injection remains a low-volume but high-value specialty diagnostic drug segment, with demand mainly driven by ophthalmic angiography, liver function and blood flow assessment, tissue perfusion evaluation, biliary visualization, lymphatic tracing and fluorescence-guided surgery. As minimally invasive surgery, oncology surgery, hepatobiliary surgery and breast surgery increasingly require real-time intraoperative visualization, ICG is evolving from a conventional diagnostic drug into a combined diagnostic and surgical navigation agent. Given the high requirements for aseptic lyophilization, stability, impurity control and regulatory compliance, the number of qualified finished-product manufacturers remains limited, and the supply structure is still specialized and regionally concentrated.
Future growth will be closely linked to the penetration of fluorescence imaging systems, endoscopic platforms, surgical robots and intraoperative navigation solutions. ICG itself is not an equipment product, but its clinical consumption is highly correlated with the installed base of fluorescence imaging systems, procedural adoption by surgeons and hospital clinical pathways. As more hospitals use fluorescence guidance for biliary imaging, lymph node mapping, perfusion assessment and tumor margin identification, the application base of Indocyanine Green for Injection is expected to expand further. Compared with traditional ophthalmic and liver-function diagnostic use, intraoperative visualization is likely to contribute more to value growth and procedural demand.
From a competitive perspective, the U.S., European and Japanese markets are mainly supported by branded formulations, established regulatory pathways and mature hospital channels, with relatively higher pricing. In China, the approval and promotion of domestic products are driving both import substitution and pricing pressure. Although the product has a relatively high unit value, the total market size remains limited, and new entrants must have capabilities in raw material quality control, aseptic lyophilized formulation production, stable supply and clinical registration. As a result, the market is unlikely to quickly become a broad commodity generics market, and leading suppliers will continue to rely on regulatory approvals, brand recognition, supply reliability and indication coverage.
Key constraints include regulatory approval requirements, clinical-use standardization, regional price differences and the evolution of alternative technologies. Indications, dosing practices, packaging requirements and clinical-use boundaries vary across countries, which increases the complexity of global registration and commercialization. In addition, dye-free imaging technologies, enhanced imaging algorithms and next-generation fluorescent probes may act as substitutes or complements in selected use cases. However, given its safety profile, cost-effectiveness, physician familiarity and accumulated clinical evidence, Indocyanine Green for Injection is expected to remain one of the most mature and accessible tracer drugs for fluorescence-guided procedures and clinical perfusion assessment in the near to medium term.
This report studies the global Indocyanine Green for Injection production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Indocyanine Green for Injection and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Indocyanine Green for Injection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Indocyanine Green for Injection total production and demand, 2021-2032, (K Units)
Global Indocyanine Green for Injection total production value, 2021-2032, (USD Million)
Global Indocyanine Green for Injection production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Indocyanine Green for Injection consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Indocyanine Green for Injection domestic production, consumption, key domestic manufacturers and share
Global Indocyanine Green for Injection production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Indocyanine Green for Injection production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Indocyanine Green for Injection production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Indocyanine Green for Injection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Diagnostic Green, Daiichi Sankyo, Nanjing Chia Tai Tianqing Pharmaceutical, Dandong Yichuang Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Indocyanine Green for Injection market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Indocyanine Green for Injection Market, By Region:
1. How big is the global Indocyanine Green for Injection market?
2. What is the demand of the global Indocyanine Green for Injection market?
3. What is the year over year growth of the global Indocyanine Green for Injection market?
4. What is the production and production value of the global Indocyanine Green for Injection market?
5. Who are the key producers in the global Indocyanine Green for Injection market?
6. What are the growth factors driving the market demand?
Indocyanine Green for Injection is a sterile injectable diagnostic drug with indocyanine green as the active ingredient, typically supplied as a 25 mg lyophilized powder for injection or a solvent-combined package. It is mainly used for liver function and hepatic blood flow assessment, ophthalmic choroidal angiography, tissue perfusion assessment, biliary visualization, lymphatic tracing, sentinel lymph node mapping and fluorescence-guided surgery. Key upstream materials include pharmaceutical-grade indocyanine green API, formulation excipients such as sodium iodide, water for injection, sterile vials, rubber stoppers, aluminum-plastic caps, lyophilized formulation packaging materials, light-protective packaging materials, and quality control consumables for sterility testing, assay testing and impurity control. Major downstream customers include general hospitals, ophthalmic specialty hospitals, hepatobiliary surgery departments, gastrointestinal surgery departments, oncology surgery departments, vascular surgery departments, transplant centers, breast surgery departments, ambulatory surgery centers and pharmaceutical distributors. On an ex-factory finished-formulation basis, global production capacity in 2025 is estimated at about 1.80 million units, with sales volume of approximately 1.127 million units, an average ex-factory price of around USD 79.5 per unit and an industry gross margin range of approximately 52%–68%. The product is a low-volume, high-value diagnostic drug with strong regulatory attributes, and its manufacturing requires strict aseptic processing, lyophilization control, visible particulate control, assay and impurity testing, sterility assurance and stability management.
The market for Indocyanine Green for Injection remains a low-volume but high-value specialty diagnostic drug segment, with demand mainly driven by ophthalmic angiography, liver function and blood flow assessment, tissue perfusion evaluation, biliary visualization, lymphatic tracing and fluorescence-guided surgery. As minimally invasive surgery, oncology surgery, hepatobiliary surgery and breast surgery increasingly require real-time intraoperative visualization, ICG is evolving from a conventional diagnostic drug into a combined diagnostic and surgical navigation agent. Given the high requirements for aseptic lyophilization, stability, impurity control and regulatory compliance, the number of qualified finished-product manufacturers remains limited, and the supply structure is still specialized and regionally concentrated.
Future growth will be closely linked to the penetration of fluorescence imaging systems, endoscopic platforms, surgical robots and intraoperative navigation solutions. ICG itself is not an equipment product, but its clinical consumption is highly correlated with the installed base of fluorescence imaging systems, procedural adoption by surgeons and hospital clinical pathways. As more hospitals use fluorescence guidance for biliary imaging, lymph node mapping, perfusion assessment and tumor margin identification, the application base of Indocyanine Green for Injection is expected to expand further. Compared with traditional ophthalmic and liver-function diagnostic use, intraoperative visualization is likely to contribute more to value growth and procedural demand.
From a competitive perspective, the U.S., European and Japanese markets are mainly supported by branded formulations, established regulatory pathways and mature hospital channels, with relatively higher pricing. In China, the approval and promotion of domestic products are driving both import substitution and pricing pressure. Although the product has a relatively high unit value, the total market size remains limited, and new entrants must have capabilities in raw material quality control, aseptic lyophilized formulation production, stable supply and clinical registration. As a result, the market is unlikely to quickly become a broad commodity generics market, and leading suppliers will continue to rely on regulatory approvals, brand recognition, supply reliability and indication coverage.
Key constraints include regulatory approval requirements, clinical-use standardization, regional price differences and the evolution of alternative technologies. Indications, dosing practices, packaging requirements and clinical-use boundaries vary across countries, which increases the complexity of global registration and commercialization. In addition, dye-free imaging technologies, enhanced imaging algorithms and next-generation fluorescent probes may act as substitutes or complements in selected use cases. However, given its safety profile, cost-effectiveness, physician familiarity and accumulated clinical evidence, Indocyanine Green for Injection is expected to remain one of the most mature and accessible tracer drugs for fluorescence-guided procedures and clinical perfusion assessment in the near to medium term.
This report studies the global Indocyanine Green for Injection production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Indocyanine Green for Injection and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Indocyanine Green for Injection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Indocyanine Green for Injection total production and demand, 2021-2032, (K Units)
Global Indocyanine Green for Injection total production value, 2021-2032, (USD Million)
Global Indocyanine Green for Injection production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Indocyanine Green for Injection consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Indocyanine Green for Injection domestic production, consumption, key domestic manufacturers and share
Global Indocyanine Green for Injection production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Indocyanine Green for Injection production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Indocyanine Green for Injection production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Indocyanine Green for Injection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Diagnostic Green, Daiichi Sankyo, Nanjing Chia Tai Tianqing Pharmaceutical, Dandong Yichuang Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Indocyanine Green for Injection market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Indocyanine Green for Injection Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- 25 mg/Vial
- 50 mg/Vial
- Hepatobiliary and Gastrointestinal Surgery
- Oncology Surgery
- Vascular and Transplant Surgery
- Ophthalmology
- Others
- Hospitals
- Specialty Clinics
- Other
- Diagnostic Green
- Daiichi Sankyo
- Nanjing Chia Tai Tianqing Pharmaceutical
- Dandong Yichuang Pharmaceutical
1. How big is the global Indocyanine Green for Injection market?
2. What is the demand of the global Indocyanine Green for Injection market?
3. What is the year over year growth of the global Indocyanine Green for Injection market?
4. What is the production and production value of the global Indocyanine Green for Injection market?
5. Who are the key producers in the global Indocyanine Green for Injection market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Indocyanine Green for Injection Introduction
1.2 World Indocyanine Green for Injection Supply & Forecast
1.2.1 World Indocyanine Green for Injection Production Value (2021 & 2025 & 2032)
1.2.2 World Indocyanine Green for Injection Production (2021-2032)
1.2.3 World Indocyanine Green for Injection Pricing Trends (2021-2032)
1.3 World Indocyanine Green for Injection Production by Region (Based on Production Site)
1.3.1 World Indocyanine Green for Injection Production Value by Region (2021-2032)
1.3.2 World Indocyanine Green for Injection Production by Region (2021-2032)
1.3.3 World Indocyanine Green for Injection Average Price by Region (2021-2032)
1.3.4 North America Indocyanine Green for Injection Production (2021-2032)
1.3.5 Europe Indocyanine Green for Injection Production (2021-2032)
1.3.6 China Indocyanine Green for Injection Production (2021-2032)
1.3.7 Japan Indocyanine Green for Injection Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Indocyanine Green for Injection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Indocyanine Green for Injection Major Market Trends
2 DEMAND SUMMARY
2.1 World Indocyanine Green for Injection Demand (2021-2032)
2.2 World Indocyanine Green for Injection Consumption by Region
2.2.1 World Indocyanine Green for Injection Consumption by Region (2021-2026)
2.2.2 World Indocyanine Green for Injection Consumption Forecast by Region (2027-2032)
2.3 United States Indocyanine Green for Injection Consumption (2021-2032)
2.4 China Indocyanine Green for Injection Consumption (2021-2032)
2.5 Europe Indocyanine Green for Injection Consumption (2021-2032)
2.6 Japan Indocyanine Green for Injection Consumption (2021-2032)
2.7 South Korea Indocyanine Green for Injection Consumption (2021-2032)
2.8 ASEAN Indocyanine Green for Injection Consumption (2021-2032)
2.9 India Indocyanine Green for Injection Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Indocyanine Green for Injection Production Value by Manufacturer (2021-2026)
3.2 World Indocyanine Green for Injection Production by Manufacturer (2021-2026)
3.3 World Indocyanine Green for Injection Average Price by Manufacturer (2021-2026)
3.4 Indocyanine Green for Injection Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Indocyanine Green for Injection Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Indocyanine Green for Injection in 2025
3.5.3 Global Concentration Ratios (CR8) for Indocyanine Green for Injection in 2025
3.6 Indocyanine Green for Injection Market: Overall Company Footprint Analysis
3.6.1 Indocyanine Green for Injection Market: Region Footprint
3.6.2 Indocyanine Green for Injection Market: Company Product Type Footprint
3.6.3 Indocyanine Green for Injection Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Indocyanine Green for Injection Production Value Comparison
4.1.1 United States VS China: Indocyanine Green for Injection Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Indocyanine Green for Injection Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Indocyanine Green for Injection Production Comparison
4.2.1 United States VS China: Indocyanine Green for Injection Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Indocyanine Green for Injection Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Indocyanine Green for Injection Consumption Comparison
4.3.1 United States VS China: Indocyanine Green for Injection Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Indocyanine Green for Injection Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Indocyanine Green for Injection Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Indocyanine Green for Injection Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Indocyanine Green for Injection Production Value (2021-2026)
4.4.3 United States Based Manufacturers Indocyanine Green for Injection Production (2021-2026)
4.5 China Based Indocyanine Green for Injection Manufacturers and Market Share
4.5.1 China Based Indocyanine Green for Injection Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Indocyanine Green for Injection Production Value (2021-2026)
4.5.3 China Based Manufacturers Indocyanine Green for Injection Production (2021-2026)
4.6 Rest of World Based Indocyanine Green for Injection Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Indocyanine Green for Injection Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Indocyanine Green for Injection Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Indocyanine Green for Injection Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Indocyanine Green for Injection Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 25 mg/Vial
5.2.2 50 mg/Vial
5.3 Market Segment by Type
5.3.1 World Indocyanine Green for Injection Production by Type (2021-2032)
5.3.2 World Indocyanine Green for Injection Production Value by Type (2021-2032)
5.3.3 World Indocyanine Green for Injection Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY END-USE DEPARTMENT
6.1 World Indocyanine Green for Injection Market Size Overview by End-use Department: 2021 VS 2025 VS 2032
6.2 Segment Introduction by End-use Department
6.2.1 Hepatobiliary and Gastrointestinal Surgery
6.2.2 Oncology Surgery
6.2.3 Vascular and Transplant Surgery
6.2.4 Ophthalmology
6.2.5 Others
6.3 Market Segment by End-use Department
6.3.1 World Indocyanine Green for Injection Production by End-use Department (2021-2032)
6.3.2 World Indocyanine Green for Injection Production Value by End-use Department (2021-2032)
6.3.3 World Indocyanine Green for Injection Average Price by End-use Department (2021-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Indocyanine Green for Injection Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Hospitals
7.2.2 Specialty Clinics
7.2.3 Other
7.3 Market Segment by Application
7.3.1 World Indocyanine Green for Injection Production by Application (2021-2032)
7.3.2 World Indocyanine Green for Injection Production Value by Application (2021-2032)
7.3.3 World Indocyanine Green for Injection Average Price by Application (2021-2032)
8 COMPANY PROFILES
8.1 Diagnostic Green
8.1.1 Diagnostic Green Details
8.1.2 Diagnostic Green Major Business
8.1.3 Diagnostic Green Indocyanine Green for Injection Product and Services
8.1.4 Diagnostic Green Indocyanine Green for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.1.5 Diagnostic Green Recent Developments/Updates
8.1.6 Diagnostic Green Competitive Strengths & Weaknesses
8.2 Daiichi Sankyo
8.2.1 Daiichi Sankyo Details
8.2.2 Daiichi Sankyo Major Business
8.2.3 Daiichi Sankyo Indocyanine Green for Injection Product and Services
8.2.4 Daiichi Sankyo Indocyanine Green for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.2.5 Daiichi Sankyo Recent Developments/Updates
8.2.6 Daiichi Sankyo Competitive Strengths & Weaknesses
8.3 Nanjing Chia Tai Tianqing Pharmaceutical
8.3.1 Nanjing Chia Tai Tianqing Pharmaceutical Details
8.3.2 Nanjing Chia Tai Tianqing Pharmaceutical Major Business
8.3.3 Nanjing Chia Tai Tianqing Pharmaceutical Indocyanine Green for Injection Product and Services
8.3.4 Nanjing Chia Tai Tianqing Pharmaceutical Indocyanine Green for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.3.5 Nanjing Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
8.3.6 Nanjing Chia Tai Tianqing Pharmaceutical Competitive Strengths & Weaknesses
8.4 Dandong Yichuang Pharmaceutical
8.4.1 Dandong Yichuang Pharmaceutical Details
8.4.2 Dandong Yichuang Pharmaceutical Major Business
8.4.3 Dandong Yichuang Pharmaceutical Indocyanine Green for Injection Product and Services
8.4.4 Dandong Yichuang Pharmaceutical Indocyanine Green for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.4.5 Dandong Yichuang Pharmaceutical Recent Developments/Updates
8.4.6 Dandong Yichuang Pharmaceutical Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Indocyanine Green for Injection Industry Chain
9.2 Indocyanine Green for Injection Upstream Analysis
9.2.1 Indocyanine Green for Injection Core Raw Materials
9.2.2 Main Manufacturers of Indocyanine Green for Injection Core Raw Materials
9.3 Midstream Analysis
9.4 Downstream Analysis
9.5 Indocyanine Green for Injection Production Mode
9.6 Indocyanine Green for Injection Procurement Model
9.7 Indocyanine Green for Injection Industry Sales Model and Sales Channels
9.7.1 Indocyanine Green for Injection Sales Model
9.7.2 Indocyanine Green for Injection Typical Distributors
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Indocyanine Green for Injection Introduction
1.2 World Indocyanine Green for Injection Supply & Forecast
1.2.1 World Indocyanine Green for Injection Production Value (2021 & 2025 & 2032)
1.2.2 World Indocyanine Green for Injection Production (2021-2032)
1.2.3 World Indocyanine Green for Injection Pricing Trends (2021-2032)
1.3 World Indocyanine Green for Injection Production by Region (Based on Production Site)
1.3.1 World Indocyanine Green for Injection Production Value by Region (2021-2032)
1.3.2 World Indocyanine Green for Injection Production by Region (2021-2032)
1.3.3 World Indocyanine Green for Injection Average Price by Region (2021-2032)
1.3.4 North America Indocyanine Green for Injection Production (2021-2032)
1.3.5 Europe Indocyanine Green for Injection Production (2021-2032)
1.3.6 China Indocyanine Green for Injection Production (2021-2032)
1.3.7 Japan Indocyanine Green for Injection Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Indocyanine Green for Injection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Indocyanine Green for Injection Major Market Trends
2 DEMAND SUMMARY
2.1 World Indocyanine Green for Injection Demand (2021-2032)
2.2 World Indocyanine Green for Injection Consumption by Region
2.2.1 World Indocyanine Green for Injection Consumption by Region (2021-2026)
2.2.2 World Indocyanine Green for Injection Consumption Forecast by Region (2027-2032)
2.3 United States Indocyanine Green for Injection Consumption (2021-2032)
2.4 China Indocyanine Green for Injection Consumption (2021-2032)
2.5 Europe Indocyanine Green for Injection Consumption (2021-2032)
2.6 Japan Indocyanine Green for Injection Consumption (2021-2032)
2.7 South Korea Indocyanine Green for Injection Consumption (2021-2032)
2.8 ASEAN Indocyanine Green for Injection Consumption (2021-2032)
2.9 India Indocyanine Green for Injection Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Indocyanine Green for Injection Production Value by Manufacturer (2021-2026)
3.2 World Indocyanine Green for Injection Production by Manufacturer (2021-2026)
3.3 World Indocyanine Green for Injection Average Price by Manufacturer (2021-2026)
3.4 Indocyanine Green for Injection Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Indocyanine Green for Injection Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Indocyanine Green for Injection in 2025
3.5.3 Global Concentration Ratios (CR8) for Indocyanine Green for Injection in 2025
3.6 Indocyanine Green for Injection Market: Overall Company Footprint Analysis
3.6.1 Indocyanine Green for Injection Market: Region Footprint
3.6.2 Indocyanine Green for Injection Market: Company Product Type Footprint
3.6.3 Indocyanine Green for Injection Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Indocyanine Green for Injection Production Value Comparison
4.1.1 United States VS China: Indocyanine Green for Injection Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Indocyanine Green for Injection Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Indocyanine Green for Injection Production Comparison
4.2.1 United States VS China: Indocyanine Green for Injection Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Indocyanine Green for Injection Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Indocyanine Green for Injection Consumption Comparison
4.3.1 United States VS China: Indocyanine Green for Injection Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Indocyanine Green for Injection Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Indocyanine Green for Injection Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Indocyanine Green for Injection Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Indocyanine Green for Injection Production Value (2021-2026)
4.4.3 United States Based Manufacturers Indocyanine Green for Injection Production (2021-2026)
4.5 China Based Indocyanine Green for Injection Manufacturers and Market Share
4.5.1 China Based Indocyanine Green for Injection Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Indocyanine Green for Injection Production Value (2021-2026)
4.5.3 China Based Manufacturers Indocyanine Green for Injection Production (2021-2026)
4.6 Rest of World Based Indocyanine Green for Injection Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Indocyanine Green for Injection Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Indocyanine Green for Injection Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Indocyanine Green for Injection Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Indocyanine Green for Injection Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 25 mg/Vial
5.2.2 50 mg/Vial
5.3 Market Segment by Type
5.3.1 World Indocyanine Green for Injection Production by Type (2021-2032)
5.3.2 World Indocyanine Green for Injection Production Value by Type (2021-2032)
5.3.3 World Indocyanine Green for Injection Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY END-USE DEPARTMENT
6.1 World Indocyanine Green for Injection Market Size Overview by End-use Department: 2021 VS 2025 VS 2032
6.2 Segment Introduction by End-use Department
6.2.1 Hepatobiliary and Gastrointestinal Surgery
6.2.2 Oncology Surgery
6.2.3 Vascular and Transplant Surgery
6.2.4 Ophthalmology
6.2.5 Others
6.3 Market Segment by End-use Department
6.3.1 World Indocyanine Green for Injection Production by End-use Department (2021-2032)
6.3.2 World Indocyanine Green for Injection Production Value by End-use Department (2021-2032)
6.3.3 World Indocyanine Green for Injection Average Price by End-use Department (2021-2032)
7 MARKET ANALYSIS BY APPLICATION
7.1 World Indocyanine Green for Injection Market Size Overview by Application: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Application
7.2.1 Hospitals
7.2.2 Specialty Clinics
7.2.3 Other
7.3 Market Segment by Application
7.3.1 World Indocyanine Green for Injection Production by Application (2021-2032)
7.3.2 World Indocyanine Green for Injection Production Value by Application (2021-2032)
7.3.3 World Indocyanine Green for Injection Average Price by Application (2021-2032)
8 COMPANY PROFILES
8.1 Diagnostic Green
8.1.1 Diagnostic Green Details
8.1.2 Diagnostic Green Major Business
8.1.3 Diagnostic Green Indocyanine Green for Injection Product and Services
8.1.4 Diagnostic Green Indocyanine Green for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.1.5 Diagnostic Green Recent Developments/Updates
8.1.6 Diagnostic Green Competitive Strengths & Weaknesses
8.2 Daiichi Sankyo
8.2.1 Daiichi Sankyo Details
8.2.2 Daiichi Sankyo Major Business
8.2.3 Daiichi Sankyo Indocyanine Green for Injection Product and Services
8.2.4 Daiichi Sankyo Indocyanine Green for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.2.5 Daiichi Sankyo Recent Developments/Updates
8.2.6 Daiichi Sankyo Competitive Strengths & Weaknesses
8.3 Nanjing Chia Tai Tianqing Pharmaceutical
8.3.1 Nanjing Chia Tai Tianqing Pharmaceutical Details
8.3.2 Nanjing Chia Tai Tianqing Pharmaceutical Major Business
8.3.3 Nanjing Chia Tai Tianqing Pharmaceutical Indocyanine Green for Injection Product and Services
8.3.4 Nanjing Chia Tai Tianqing Pharmaceutical Indocyanine Green for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.3.5 Nanjing Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
8.3.6 Nanjing Chia Tai Tianqing Pharmaceutical Competitive Strengths & Weaknesses
8.4 Dandong Yichuang Pharmaceutical
8.4.1 Dandong Yichuang Pharmaceutical Details
8.4.2 Dandong Yichuang Pharmaceutical Major Business
8.4.3 Dandong Yichuang Pharmaceutical Indocyanine Green for Injection Product and Services
8.4.4 Dandong Yichuang Pharmaceutical Indocyanine Green for Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
8.4.5 Dandong Yichuang Pharmaceutical Recent Developments/Updates
8.4.6 Dandong Yichuang Pharmaceutical Competitive Strengths & Weaknesses
9 INDUSTRY CHAIN ANALYSIS
9.1 Indocyanine Green for Injection Industry Chain
9.2 Indocyanine Green for Injection Upstream Analysis
9.2.1 Indocyanine Green for Injection Core Raw Materials
9.2.2 Main Manufacturers of Indocyanine Green for Injection Core Raw Materials
9.3 Midstream Analysis
9.4 Downstream Analysis
9.5 Indocyanine Green for Injection Production Mode
9.6 Indocyanine Green for Injection Procurement Model
9.7 Indocyanine Green for Injection Industry Sales Model and Sales Channels
9.7.1 Indocyanine Green for Injection Sales Model
9.7.2 Indocyanine Green for Injection Typical Distributors
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Indocyanine Green for Injection Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Indocyanine Green for Injection Production Value by Region (2021-2026) & (USD Million)
Table 3. World Indocyanine Green for Injection Production Value by Region (2027-2032) & (USD Million)
Table 4. World Indocyanine Green for Injection Production Value Market Share by Region (2021-2026)
Table 5. World Indocyanine Green for Injection Production Value Market Share by Region (2027-2032)
Table 6. World Indocyanine Green for Injection Production by Region (2021-2026) & (K Units)
Table 7. World Indocyanine Green for Injection Production by Region (2027-2032) & (K Units)
Table 8. World Indocyanine Green for Injection Production Market Share by Region (2021-2026)
Table 9. World Indocyanine Green for Injection Production Market Share by Region (2027-2032)
Table 10. World Indocyanine Green for Injection Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Indocyanine Green for Injection Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Indocyanine Green for Injection Major Market Trends
Table 13. World Indocyanine Green for Injection Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Indocyanine Green for Injection Consumption by Region (2021-2026) & (K Units)
Table 15. World Indocyanine Green for Injection Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Indocyanine Green for Injection Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Indocyanine Green for Injection Producers in 2025
Table 18. World Indocyanine Green for Injection Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Indocyanine Green for Injection Producers in 2025
Table 20. World Indocyanine Green for Injection Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Indocyanine Green for Injection Company Evaluation Quadrant
Table 22. World Indocyanine Green for Injection Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Indocyanine Green for Injection Production Site of Key Manufacturer
Table 24. Indocyanine Green for Injection Market: Company Product Type Footprint
Table 25. Indocyanine Green for Injection Market: Company Product Application Footprint
Table 26. Indocyanine Green for Injection Competitive Factors
Table 27. Indocyanine Green for Injection New Entrant and Capacity Expansion Plans
Table 28. Indocyanine Green for Injection Mergers & Acquisitions Activity
Table 29. United States VS China Indocyanine Green for Injection Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Indocyanine Green for Injection Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Indocyanine Green for Injection Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Indocyanine Green for Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Indocyanine Green for Injection Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Indocyanine Green for Injection Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Indocyanine Green for Injection Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Indocyanine Green for Injection Production Market Share (2021-2026)
Table 37. China Based Indocyanine Green for Injection Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Indocyanine Green for Injection Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Indocyanine Green for Injection Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Indocyanine Green for Injection Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Indocyanine Green for Injection Production Market Share (2021-2026)
Table 42. Rest of World Based Indocyanine Green for Injection Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Indocyanine Green for Injection Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Indocyanine Green for Injection Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Indocyanine Green for Injection Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Indocyanine Green for Injection Production Market Share (2021-2026)
Table 47. World Indocyanine Green for Injection Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Indocyanine Green for Injection Production by Type (2021-2026) & (K Units)
Table 49. World Indocyanine Green for Injection Production by Type (2027-2032) & (K Units)
Table 50. World Indocyanine Green for Injection Production Value by Type (2021-2026) & (USD Million)
Table 51. World Indocyanine Green for Injection Production Value by Type (2027-2032) & (USD Million)
Table 52. World Indocyanine Green for Injection Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Indocyanine Green for Injection Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Indocyanine Green for Injection Production Value by End-use Department, (USD Million), 2021 & 2025 & 2032
Table 55. World Indocyanine Green for Injection Production by End-use Department (2021-2026) & (K Units)
Table 56. World Indocyanine Green for Injection Production by End-use Department (2027-2032) & (K Units)
Table 57. World Indocyanine Green for Injection Production Value by End-use Department (2021-2026) & (USD Million)
Table 58. World Indocyanine Green for Injection Production Value by End-use Department (2027-2032) & (USD Million)
Table 59. World Indocyanine Green for Injection Average Price by End-use Department (2021-2026) & (US$/Unit)
Table 60. World Indocyanine Green for Injection Average Price by End-use Department (2027-2032) & (US$/Unit)
Table 61. World Indocyanine Green for Injection Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 62. World Indocyanine Green for Injection Production by Application (2021-2026) & (K Units)
Table 63. World Indocyanine Green for Injection Production by Application (2027-2032) & (K Units)
Table 64. World Indocyanine Green for Injection Production Value by Application (2021-2026) & (USD Million)
Table 65. World Indocyanine Green for Injection Production Value by Application (2027-2032) & (USD Million)
Table 66. World Indocyanine Green for Injection Average Price by Application (2021-2026) & (US$/Unit)
Table 67. World Indocyanine Green for Injection Average Price by Application (2027-2032) & (US$/Unit)
Table 68. Diagnostic Green Basic Information, Manufacturing Base and Competitors
Table 69. Diagnostic Green Major Business
Table 70. Diagnostic Green Indocyanine Green for Injection Product and Services
Table 71. Diagnostic Green Indocyanine Green for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Diagnostic Green Recent Developments/Updates
Table 73. Diagnostic Green Competitive Strengths & Weaknesses
Table 74. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 75. Daiichi Sankyo Major Business
Table 76. Daiichi Sankyo Indocyanine Green for Injection Product and Services
Table 77. Daiichi Sankyo Indocyanine Green for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. Daiichi Sankyo Recent Developments/Updates
Table 79. Daiichi Sankyo Competitive Strengths & Weaknesses
Table 80. Nanjing Chia Tai Tianqing Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 81. Nanjing Chia Tai Tianqing Pharmaceutical Major Business
Table 82. Nanjing Chia Tai Tianqing Pharmaceutical Indocyanine Green for Injection Product and Services
Table 83. Nanjing Chia Tai Tianqing Pharmaceutical Indocyanine Green for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Nanjing Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
Table 85. Nanjing Chia Tai Tianqing Pharmaceutical Competitive Strengths & Weaknesses
Table 86. Dandong Yichuang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 87. Dandong Yichuang Pharmaceutical Major Business
Table 88. Dandong Yichuang Pharmaceutical Indocyanine Green for Injection Product and Services
Table 89. Dandong Yichuang Pharmaceutical Indocyanine Green for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Dandong Yichuang Pharmaceutical Recent Developments/Updates
Table 91. Dandong Yichuang Pharmaceutical Competitive Strengths & Weaknesses
Table 92. Global Key Players of Indocyanine Green for Injection Upstream (Raw Materials)
Table 93. Global Indocyanine Green for Injection Typical Customers
Table 94. Indocyanine Green for Injection Typical Distributors
Table 1. World Indocyanine Green for Injection Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Indocyanine Green for Injection Production Value by Region (2021-2026) & (USD Million)
Table 3. World Indocyanine Green for Injection Production Value by Region (2027-2032) & (USD Million)
Table 4. World Indocyanine Green for Injection Production Value Market Share by Region (2021-2026)
Table 5. World Indocyanine Green for Injection Production Value Market Share by Region (2027-2032)
Table 6. World Indocyanine Green for Injection Production by Region (2021-2026) & (K Units)
Table 7. World Indocyanine Green for Injection Production by Region (2027-2032) & (K Units)
Table 8. World Indocyanine Green for Injection Production Market Share by Region (2021-2026)
Table 9. World Indocyanine Green for Injection Production Market Share by Region (2027-2032)
Table 10. World Indocyanine Green for Injection Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Indocyanine Green for Injection Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Indocyanine Green for Injection Major Market Trends
Table 13. World Indocyanine Green for Injection Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Indocyanine Green for Injection Consumption by Region (2021-2026) & (K Units)
Table 15. World Indocyanine Green for Injection Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Indocyanine Green for Injection Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Indocyanine Green for Injection Producers in 2025
Table 18. World Indocyanine Green for Injection Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Indocyanine Green for Injection Producers in 2025
Table 20. World Indocyanine Green for Injection Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Indocyanine Green for Injection Company Evaluation Quadrant
Table 22. World Indocyanine Green for Injection Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Indocyanine Green for Injection Production Site of Key Manufacturer
Table 24. Indocyanine Green for Injection Market: Company Product Type Footprint
Table 25. Indocyanine Green for Injection Market: Company Product Application Footprint
Table 26. Indocyanine Green for Injection Competitive Factors
Table 27. Indocyanine Green for Injection New Entrant and Capacity Expansion Plans
Table 28. Indocyanine Green for Injection Mergers & Acquisitions Activity
Table 29. United States VS China Indocyanine Green for Injection Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Indocyanine Green for Injection Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Indocyanine Green for Injection Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Indocyanine Green for Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Indocyanine Green for Injection Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Indocyanine Green for Injection Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Indocyanine Green for Injection Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Indocyanine Green for Injection Production Market Share (2021-2026)
Table 37. China Based Indocyanine Green for Injection Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Indocyanine Green for Injection Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Indocyanine Green for Injection Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Indocyanine Green for Injection Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Indocyanine Green for Injection Production Market Share (2021-2026)
Table 42. Rest of World Based Indocyanine Green for Injection Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Indocyanine Green for Injection Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Indocyanine Green for Injection Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Indocyanine Green for Injection Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Indocyanine Green for Injection Production Market Share (2021-2026)
Table 47. World Indocyanine Green for Injection Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Indocyanine Green for Injection Production by Type (2021-2026) & (K Units)
Table 49. World Indocyanine Green for Injection Production by Type (2027-2032) & (K Units)
Table 50. World Indocyanine Green for Injection Production Value by Type (2021-2026) & (USD Million)
Table 51. World Indocyanine Green for Injection Production Value by Type (2027-2032) & (USD Million)
Table 52. World Indocyanine Green for Injection Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Indocyanine Green for Injection Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Indocyanine Green for Injection Production Value by End-use Department, (USD Million), 2021 & 2025 & 2032
Table 55. World Indocyanine Green for Injection Production by End-use Department (2021-2026) & (K Units)
Table 56. World Indocyanine Green for Injection Production by End-use Department (2027-2032) & (K Units)
Table 57. World Indocyanine Green for Injection Production Value by End-use Department (2021-2026) & (USD Million)
Table 58. World Indocyanine Green for Injection Production Value by End-use Department (2027-2032) & (USD Million)
Table 59. World Indocyanine Green for Injection Average Price by End-use Department (2021-2026) & (US$/Unit)
Table 60. World Indocyanine Green for Injection Average Price by End-use Department (2027-2032) & (US$/Unit)
Table 61. World Indocyanine Green for Injection Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 62. World Indocyanine Green for Injection Production by Application (2021-2026) & (K Units)
Table 63. World Indocyanine Green for Injection Production by Application (2027-2032) & (K Units)
Table 64. World Indocyanine Green for Injection Production Value by Application (2021-2026) & (USD Million)
Table 65. World Indocyanine Green for Injection Production Value by Application (2027-2032) & (USD Million)
Table 66. World Indocyanine Green for Injection Average Price by Application (2021-2026) & (US$/Unit)
Table 67. World Indocyanine Green for Injection Average Price by Application (2027-2032) & (US$/Unit)
Table 68. Diagnostic Green Basic Information, Manufacturing Base and Competitors
Table 69. Diagnostic Green Major Business
Table 70. Diagnostic Green Indocyanine Green for Injection Product and Services
Table 71. Diagnostic Green Indocyanine Green for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 72. Diagnostic Green Recent Developments/Updates
Table 73. Diagnostic Green Competitive Strengths & Weaknesses
Table 74. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 75. Daiichi Sankyo Major Business
Table 76. Daiichi Sankyo Indocyanine Green for Injection Product and Services
Table 77. Daiichi Sankyo Indocyanine Green for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. Daiichi Sankyo Recent Developments/Updates
Table 79. Daiichi Sankyo Competitive Strengths & Weaknesses
Table 80. Nanjing Chia Tai Tianqing Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 81. Nanjing Chia Tai Tianqing Pharmaceutical Major Business
Table 82. Nanjing Chia Tai Tianqing Pharmaceutical Indocyanine Green for Injection Product and Services
Table 83. Nanjing Chia Tai Tianqing Pharmaceutical Indocyanine Green for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Nanjing Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
Table 85. Nanjing Chia Tai Tianqing Pharmaceutical Competitive Strengths & Weaknesses
Table 86. Dandong Yichuang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 87. Dandong Yichuang Pharmaceutical Major Business
Table 88. Dandong Yichuang Pharmaceutical Indocyanine Green for Injection Product and Services
Table 89. Dandong Yichuang Pharmaceutical Indocyanine Green for Injection Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Dandong Yichuang Pharmaceutical Recent Developments/Updates
Table 91. Dandong Yichuang Pharmaceutical Competitive Strengths & Weaknesses
Table 92. Global Key Players of Indocyanine Green for Injection Upstream (Raw Materials)
Table 93. Global Indocyanine Green for Injection Typical Customers
Table 94. Indocyanine Green for Injection Typical Distributors
LIST OF FIGURES
Figure 1. Indocyanine Green for Injection Picture
Figure 2. World Indocyanine Green for Injection Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Indocyanine Green for Injection Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Indocyanine Green for Injection Production (2021-2032) & (K Units)
Figure 5. World Indocyanine Green for Injection Average Price (2021-2032) & (US$/Unit)
Figure 6. World Indocyanine Green for Injection Production Value Market Share by Region (2021-2032)
Figure 7. World Indocyanine Green for Injection Production Market Share by Region (2021-2032)
Figure 8. North America Indocyanine Green for Injection Production (2021-2032) & (K Units)
Figure 9. Europe Indocyanine Green for Injection Production (2021-2032) & (K Units)
Figure 10. China Indocyanine Green for Injection Production (2021-2032) & (K Units)
Figure 11. Japan Indocyanine Green for Injection Production (2021-2032) & (K Units)
Figure 12. Indocyanine Green for Injection Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Indocyanine Green for Injection Consumption (2021-2032) & (K Units)
Figure 15. World Indocyanine Green for Injection Consumption Market Share by Region (2021-2032)
Figure 16. United States Indocyanine Green for Injection Consumption (2021-2032) & (K Units)
Figure 17. China Indocyanine Green for Injection Consumption (2021-2032) & (K Units)
Figure 18. Europe Indocyanine Green for Injection Consumption (2021-2032) & (K Units)
Figure 19. Japan Indocyanine Green for Injection Consumption (2021-2032) & (K Units)
Figure 20. South Korea Indocyanine Green for Injection Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Indocyanine Green for Injection Consumption (2021-2032) & (K Units)
Figure 22. India Indocyanine Green for Injection Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Indocyanine Green for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Indocyanine Green for Injection Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Indocyanine Green for Injection Markets in 2025
Figure 26. United States VS China: Indocyanine Green for Injection Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Indocyanine Green for Injection Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Indocyanine Green for Injection Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Indocyanine Green for Injection Production Market Share 2025
Figure 30. China Based Manufacturers Indocyanine Green for Injection Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Indocyanine Green for Injection Production Market Share 2025
Figure 32. World Indocyanine Green for Injection Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Indocyanine Green for Injection Production Value Market Share by Type in 2025
Figure 34. 25 mg/Vial
Figure 35. 50 mg/Vial
Figure 36. World Indocyanine Green for Injection Production Market Share by Type (2021-2032)
Figure 37. World Indocyanine Green for Injection Production Value Market Share by Type (2021-2032)
Figure 38. World Indocyanine Green for Injection Average Price by Type (2021-2032) & (US$/Unit)
Figure 39. World Indocyanine Green for Injection Production Value by End-use Department, (USD Million), 2021 & 2025 & 2032
Figure 40. World Indocyanine Green for Injection Production Value Market Share by End-use Department in 2025
Figure 41. Hepatobiliary and Gastrointestinal Surgery
Figure 42. Oncology Surgery
Figure 43. Vascular and Transplant Surgery
Figure 44. Ophthalmology
Figure 45. Others
Figure 46. World Indocyanine Green for Injection Production Market Share by End-use Department (2021-2032)
Figure 47. World Indocyanine Green for Injection Production Value Market Share by End-use Department (2021-2032)
Figure 48. World Indocyanine Green for Injection Average Price by End-use Department (2021-2032) & (US$/Unit)
Figure 49. World Indocyanine Green for Injection Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 50. World Indocyanine Green for Injection Production Value Market Share by Application in 2025
Figure 51. Hospitals
Figure 52. Specialty Clinics
Figure 53. Other
Figure 54. World Indocyanine Green for Injection Production Market Share by Application (2021-2032)
Figure 55. World Indocyanine Green for Injection Production Value Market Share by Application (2021-2032)
Figure 56. World Indocyanine Green for Injection Average Price by Application (2021-2032) & (US$/Unit)
Figure 57. Indocyanine Green for Injection Industry Chain
Figure 58. Indocyanine Green for Injection Procurement Model
Figure 59. Indocyanine Green for Injection Sales Model
Figure 60. Indocyanine Green for Injection Sales Channels, Direct Sales, and Distribution
Figure 61. Methodology
Figure 62. Research Process and Data Source
Figure 1. Indocyanine Green for Injection Picture
Figure 2. World Indocyanine Green for Injection Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Indocyanine Green for Injection Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Indocyanine Green for Injection Production (2021-2032) & (K Units)
Figure 5. World Indocyanine Green for Injection Average Price (2021-2032) & (US$/Unit)
Figure 6. World Indocyanine Green for Injection Production Value Market Share by Region (2021-2032)
Figure 7. World Indocyanine Green for Injection Production Market Share by Region (2021-2032)
Figure 8. North America Indocyanine Green for Injection Production (2021-2032) & (K Units)
Figure 9. Europe Indocyanine Green for Injection Production (2021-2032) & (K Units)
Figure 10. China Indocyanine Green for Injection Production (2021-2032) & (K Units)
Figure 11. Japan Indocyanine Green for Injection Production (2021-2032) & (K Units)
Figure 12. Indocyanine Green for Injection Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Indocyanine Green for Injection Consumption (2021-2032) & (K Units)
Figure 15. World Indocyanine Green for Injection Consumption Market Share by Region (2021-2032)
Figure 16. United States Indocyanine Green for Injection Consumption (2021-2032) & (K Units)
Figure 17. China Indocyanine Green for Injection Consumption (2021-2032) & (K Units)
Figure 18. Europe Indocyanine Green for Injection Consumption (2021-2032) & (K Units)
Figure 19. Japan Indocyanine Green for Injection Consumption (2021-2032) & (K Units)
Figure 20. South Korea Indocyanine Green for Injection Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Indocyanine Green for Injection Consumption (2021-2032) & (K Units)
Figure 22. India Indocyanine Green for Injection Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Indocyanine Green for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Indocyanine Green for Injection Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Indocyanine Green for Injection Markets in 2025
Figure 26. United States VS China: Indocyanine Green for Injection Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Indocyanine Green for Injection Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Indocyanine Green for Injection Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Indocyanine Green for Injection Production Market Share 2025
Figure 30. China Based Manufacturers Indocyanine Green for Injection Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Indocyanine Green for Injection Production Market Share 2025
Figure 32. World Indocyanine Green for Injection Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Indocyanine Green for Injection Production Value Market Share by Type in 2025
Figure 34. 25 mg/Vial
Figure 35. 50 mg/Vial
Figure 36. World Indocyanine Green for Injection Production Market Share by Type (2021-2032)
Figure 37. World Indocyanine Green for Injection Production Value Market Share by Type (2021-2032)
Figure 38. World Indocyanine Green for Injection Average Price by Type (2021-2032) & (US$/Unit)
Figure 39. World Indocyanine Green for Injection Production Value by End-use Department, (USD Million), 2021 & 2025 & 2032
Figure 40. World Indocyanine Green for Injection Production Value Market Share by End-use Department in 2025
Figure 41. Hepatobiliary and Gastrointestinal Surgery
Figure 42. Oncology Surgery
Figure 43. Vascular and Transplant Surgery
Figure 44. Ophthalmology
Figure 45. Others
Figure 46. World Indocyanine Green for Injection Production Market Share by End-use Department (2021-2032)
Figure 47. World Indocyanine Green for Injection Production Value Market Share by End-use Department (2021-2032)
Figure 48. World Indocyanine Green for Injection Average Price by End-use Department (2021-2032) & (US$/Unit)
Figure 49. World Indocyanine Green for Injection Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 50. World Indocyanine Green for Injection Production Value Market Share by Application in 2025
Figure 51. Hospitals
Figure 52. Specialty Clinics
Figure 53. Other
Figure 54. World Indocyanine Green for Injection Production Market Share by Application (2021-2032)
Figure 55. World Indocyanine Green for Injection Production Value Market Share by Application (2021-2032)
Figure 56. World Indocyanine Green for Injection Average Price by Application (2021-2032) & (US$/Unit)
Figure 57. Indocyanine Green for Injection Industry Chain
Figure 58. Indocyanine Green for Injection Procurement Model
Figure 59. Indocyanine Green for Injection Sales Model
Figure 60. Indocyanine Green for Injection Sales Channels, Direct Sales, and Distribution
Figure 61. Methodology
Figure 62. Research Process and Data Source
